Company intelligence / Profile preview

DeLondra Oncology

Wilmslow, England, United Kingdom

Ownership: Private
Employees: ~4
Development stage: Other

Overview

DeLondra Oncology is a UK-based oncology drug development consultancy focused on early clinical and translational development rather than building its own therapeutic pipeline. The firm provides pharmaceutical medicine consulting services to large pharmaceutical companies and oncology biotech companies across Europe, North America, and Asia. Its work appears centered on strategy and execution in early oncology clinical development, including translational and clinical development support. Publicly available information indicates the company was founded in 2018 and is led by Dónal Landers, an experienced pharmaceutical physician with prior leadership roles in oncology development.

Therapeutic areas: Oncology
Industry: Consulting

Beyond the preview

Go deeper on DeLondra Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DeLondra Oncology.

Explore the full profile